[{"Physician_Profile_ID": "538515", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "ELI LILLY AND COMPANY", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000088", "Total_Amount_of_Payment_USDollars": "1175.00", "Date_of_Payment": "01/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "144081846", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE -A4 STUDY", "Research_Information_Link": "http://clinicaltrials.gov/ct2/show/NCT02008357", "Context_of_Research": "THE AMOUNT REPORTED REPRESENTS EITHER AN AGGREGATE OF CASH PAYMENTS -E.G. CLINICAL STUDY SERVICES, REIMBURSEMENTS FOR EXPENSES OR PASS-THROUGH COSTS- OR AN AGGREGATE OF IN-KIND VALUE -E.G. SUPPLIES, EQUIPMENT- PROVIDED BY LILLY OR BY A THIRD PARTY VENDOR IN CONNECTION WITH CLINICAL STUDIES DURING THE REPORTING PERIOD.  FOR AVAILABLE STUDY DETAILS, PLEASE VISIT CLINICALTRIALS.GOV."}]